FDMT
4D Molecular Therapeutics Inc
NASDAQ: FDMT · HEALTHCARE · BIOTECHNOLOGY
$8.87
+0.68% today
Updated 2026-04-30
Market cap
$479.88M
P/E ratio
—
P/S ratio
5.63x
EPS (TTM)
$-2.42
Dividend yield
—
52W range
$3 – $12
Volume
0.8M
4D Molecular Therapeutics Inc (FDMT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+36.7%
Last 4 quarters
Revenue YoY growth
+8508900.0%
Most recent quarter
EPS YoY growth
+147.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.4%
2026-02-27
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-27 | $0.43 | +180.8% | $9.66 | $9.33 | -3.4% |
| 2025-11-10 | $-1.01 | +0.0% | $10.50 | $10.80 | +2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.53 | $0.43 | +180.8% | $85.09M | +8508900.0% |
| 2025-09-30 | $-1.01 | $-1.01 | +0.0% | $90000.00 | +2900.0% |
| 2025-06-30 | $-0.73 | $-0.98 | -34.2% | $15000.00 | +200.0% |
| 2025-03-31 | $-0.86 | $-0.86 | +0.2% | $14000.00 | -50.0% |
| 2024-12-31 | $-0.84 | $-0.90 | -7.4% | $1000.00 | -105.3% |
| 2024-09-30 | $-0.70 | $-0.79 | -12.9% | $3000.00 | -100.0% |
| 2024-06-30 | $-0.70 | $-0.63 | +10.0% | $5000.00 | -97.9% |
| 2024-03-31 | $-0.74 | $-0.66 | +10.8% | $28000.00 | -90.6% |
| 2023-12-31 | $-0.74 | $-0.75 | -1.4% | $-19000.00 | — |
| 2023-09-30 | $-0.59 | $-0.24 | +59.3% | $20.20M | — |
| 2023-06-30 | $-0.81 | $-0.77 | +4.9% | $239000.00 | — |
| 2023-03-31 | $-0.89 | $-0.88 | +1.1% | $298000.00 | — |
Frequently asked questions
Has 4D Molecular Therapeutics Inc beaten earnings estimates?
4D Molecular Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +36.7% over the last 4 quarters.
How does FDMT stock react to earnings?
FDMT stock has moved an average of -0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is 4D Molecular Therapeutics Inc's revenue growth rate?
4D Molecular Therapeutics Inc reported year-over-year revenue growth of +8508900.0% in its most recent quarter, with EPS growing +147.8% year-over-year.